访问量:   最后更新时间:--

郝海红

博士生导师
硕士生导师
教师姓名:郝海红
教师英文名称:High
教师拼音名称:haohaihong
电子邮箱:
所在单位:动物科学技术学院、动物医学院
学历:博士研究生毕业
办公地点:华中农业大学国家兽药残留基准实验室118
学位:博士
职称:教授
在职信息:在职
毕业院校:华中农业大学
所属院系:动物科学技术学院、动物医学院
学科:兽医学其他专业    基础兽医学    
其他联系方式

邮编:

通讯/办公地址:

论文成果
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift
发布时间:2022-03-03    点击次数:

影响因子:5.64

DOI码:10.3389/fmicb.2021.712473

发表刊物:2021 Sep 9;12:712473. do

项目来源:National Key Research and Development Program (2016YFD0501302 and 2017YFD0501406), the National Natu

关键字:Mycoplasma gallisepticum, tylosin, dosage regimen, clinical breakpoint, lung microbiota

摘要:The aim of this study was to explore the prudent use of tylosin for the treatment of chronic respiratory infectious diseases in chickens caused by Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and its effect on lung microbiota. The CBP was established based on the wild-type/epidemiological cutoff value (COWT/ECV), pharmacokinetics-pharmacodynamics (PK-PD) cutoff value (COPD), and clinical cutoff value (COCL) of tylosin against MG. The minimum inhibitory concentration (MIC) of tylosin against 111 MG isolates was analyzed and the COWT was 2 μg/ml. M17 with MIC of 2 μg/ml was selected as a representative strain for the PK-PD study. The COPD of tylosin against MG was 1 μg/ml. The dosage regimen formulated by the PK-PD study was 3 days administration of tylosin at a dose of 45.88 mg/kg b.w. with a 24-h interval. Five different MIC MGs were selected for clinical trial, and the COCL of tylosin against MG was 0.5 μg/ml. According to the CLSI decision tree, the CBP of tylosin against MG was set up as 2 μg/ml. The effect of tylosin on lung microbiota of MG-infected chickens was analyzed by 16S rRNA gene sequencing. Significant change of the lung microbiota was observed in the infection group and treatment group based on the principal coordinate analysis and the Venn diagrams of the core and unique OTU. The phyla Firmicutes and Proteobacteria showed difference after MG infection and treatment. This study established the CBP of tylosin against MG. It also provided scientific data for the prudent use of tylosin based on the evaluation of MG infection and tylosin treatment on the lung microbiota.

合写作者:Shuge Wang,Jinli Guo,Yufeng Gu,Jun Li,Lingli Huang,Xu Wang,Yanfei Tao,Zhenli Liu,Zonghui Yuan

第一作者:Anxiong Huang

论文类型:期刊论文

通讯作者:Haihong Hao

论文编号:712473

卷号:12

字数:5000

是否译文:

发表时间:2021-09-09

收录刊物:SCI

发布期刊链接:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458857/